<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oncotarget</journal-id><journal-id journal-id-type="iso-abbrev">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">ImpactJ</journal-id><journal-title-group><journal-title>Oncotarget</journal-title></journal-title-group><issn pub-type="epub">1949-2553</issn><publisher><publisher-name>Impact Journals LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4890983</article-id><article-id pub-id-type="pmid">26885755</article-id><article-id pub-id-type="publisher-id">7382</article-id><article-id pub-id-type="doi">10.18632/oncotarget.7382</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Paper: Gerotarget (Focus on Aging)</subject></subj-group></article-categories><title-group><article-title>Molecular signatures of age-associated chronic degeneration of shoulder muscles</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Raz</surname><given-names>Yotam</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref><xref ref-type="aff" rid="A3"><sup>3</sup></xref><xref ref-type="author-notes" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Henseler</surname><given-names>Jan Ferdinand</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="author-notes" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Kolk</surname><given-names>Arjen</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tatum</surname><given-names>Zuotian</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Groosjohan</surname><given-names>Niels Kuipers</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Verwey</surname><given-names>Nisha E.</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Arindrarto</surname><given-names>Wibowo</given-names></name><xref ref-type="aff" rid="A3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kielbasa</surname><given-names>Szymon M.</given-names></name><xref ref-type="aff" rid="A3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nagels</surname><given-names>Jochem</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hoen</surname><given-names>Peter A. C. 't</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nelissen</surname><given-names>Rob G. H. H.</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Raz</surname><given-names>Vered</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib></contrib-group><aff id="A1"><sup>1</sup> Department of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands</aff><aff id="A2"><sup>2</sup> Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands</aff><aff id="A3"><sup>3</sup> Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands</aff><author-notes><corresp id="cor1"><bold><italic>Correspondence to:</italic></bold><italic>Vered Raz,</italic><email>v.raz@lumc.nl</email></corresp><fn id="FN1"><label>*</label><p>Equal first authorship</p></fn></author-notes><pub-date pub-type="collection"><day>23</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>14</day><month>2</month><year>2016</year></pub-date><volume>7</volume><issue>8</issue><fpage>8513</fpage><lpage>8523</lpage><history><date date-type="received"><day>8</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>30</day><month>1</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2016 Raz et al.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><p>Chronic muscle diseases are highly prevalent in the elderly causing severe mobility limitations, pain and frailty. The intrinsic molecular mechanisms are poorly understood due to multifactorial causes, slow progression with age and variations between individuals. Understanding the underlying molecular mechanisms could lead to new treatment options which are currently limited. Shoulder complaints are highly common in the elderly, and therefore, muscles of the shoulder's rotator cuff could be considered as a model for chronic age-associated muscle degeneration. Diseased shoulder muscles were characterized by muscle atrophy and fatty infiltration compared with unaffected shoulder muscles. We confirmed fatty infiltration using histochemical analysis. Additionally, fibrosis and loss of contractile myosin expression were found in diseased muscles. Most cellular features, including proliferation rate, apoptosis and cell senescence, remained unchanged and genome-wide molecular signatures were predominantly similar between diseased and intact muscles. However, we found down-regulation of a small subset of muscle function genes, and up-regulation of extracellular region genes. Myogenesis was defected in muscle cell culture from diseased muscles but was restored by elevating MyoD levels. We suggest that impaired muscle functionality in a specific environment of thickened extra-cellular matrix is crucial for the development of chronic age-associated muscle degeneration.</p></abstract><kwd-group><kwd>shoulder disease</kwd><kwd>atrophy</kwd><kwd>fatty infiltration</kwd><kwd>muscle satellite cells</kwd><kwd>deep RNA-seq</kwd><kwd>Gerotarget</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>INTRODUCTION</title><p>Aging-associated muscle degeneration leads to functional impairments of daily activities of the elderly due to immobility and frailty. Muscle degeneration is prominent in neuromuscular disorders [<xref rid="R1" ref-type="bibr">1</xref>] and acute muscle disuse conditions [<xref rid="R2" ref-type="bibr">2</xref>]. In these conditions discovery of the associated molecular mechanisms have led to better understanding of the pathophysiological processes of these disorders [<xref rid="R3" ref-type="bibr">3</xref>]. However, the molecular changes occurring in muscle degeneration in chronic conditions are still not fully understood. This is partly due to multifactorial etiologies, slow progression with aging, variation between individuals and unavailability of suitable models. Shoulder complaints are common in the general population [<xref rid="R4" ref-type="bibr">4</xref>-<xref rid="R6" ref-type="bibr">6</xref>], and their prevalence progresses during aging to more than 40% [<xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R8" ref-type="bibr">8</xref>]. Disease in the shoulder's rotator cuff (RC) muscles is characterized by disability of the shoulder joint, leading to pain and functional impairment in daily activities. The four RC muscles function as intricate motor units that dynamically stabilize the shoulder joint and provide arm mobility [<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R10" ref-type="bibr">10</xref>]. Initially, studies focused on the tendon degeneration [<xref rid="R11" ref-type="bibr">11</xref>-<xref rid="R15" ref-type="bibr">15</xref>], but recently muscle degeneration has been suggested to be primarily involved in affected RC muscles [<xref rid="R16" ref-type="bibr">16</xref>, <xref rid="R17" ref-type="bibr">17</xref>]. Importantly, muscle degeneration in the shoulder is considered as a clinical determinant for surgical and non-surgical treatment outcomes [<xref rid="R16" ref-type="bibr">16</xref>, <xref rid="R18" ref-type="bibr">18</xref>-<xref rid="R20" ref-type="bibr">20</xref>]. However, variable and non-sustained outcomes call for better understanding of the intricate balance of shoulder pathology and functionality [<xref rid="R21" ref-type="bibr">21</xref>, <xref rid="R22" ref-type="bibr">22</xref>].</p><p>Within the spectrum of chronic muscle disease tearing of the shoulder's RC is common. In RC tears the supraspinatus muscle (SSp) is initially affected and as the disease progresses, the subscapularis muscle (SSc) can tear as well [<xref rid="R23" ref-type="bibr">23</xref>]. In chronic RC diseases the deltoid muscle (DM) is clinically not affected, and can be considered a reference muscle [<xref rid="R17" ref-type="bibr">17</xref>]. Previously, we showed that while atrophy in the SSp and SSc continuously increase throughout adulthood, atrophy in the other RC muscles and the DM starts only from midlife onwards [<xref rid="R17" ref-type="bibr">17</xref>]. Furthermore, we found that torn RC muscles are characterized by an increase in extracellular matrix, and fatty droplets [<xref rid="R17" ref-type="bibr">17</xref>]. Despite high Pax-7 positive cells in torn muscles, their regeneration is limited [<xref rid="R17" ref-type="bibr">17</xref>]. Yet, the molecular mechanisms associated with these pathological conditions remain unknown.</p><p>Shoulder surgery provides a unique opportunity for ex-vivo investigations of functionally impaired muscles compared with unaffected muscles. Here we report a multidisciplinary study integrating radiological, histological, cellular and molecular investigations of diseased SSc and unaffected DM. We show that the SSc is highly degenerated and fibrotic but in contrast, viable muscle cell cultures were generated from both SSc and DM. Muscle cell cultures of SSc were predominantly indifferent from DM. However, reduced myogenesis in SSc cultures was associated with down-regulation of genes regulating muscle development as well as up-regulation of extracellular region genes.</p></sec><sec id="s2"><title>RESULTS</title><sec id="s2_1"><title>Clinical characteristics</title><p>Clinical features of diseased RC muscles were assessed from radiological imaging from 28 patients who underwent shoulder surgery. We compared RC muscle atrophy and fatty infiltration from patients with a diseased SSc with control subjects having an intact RC (Figure <xref ref-type="fig" rid="F1">1</xref>).</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Clinical description of deltoid and subscapularis muscles</title><p>Anatomical landmarks of shoulder muscles in intact and torn conditions. Representative MRA images from the control group (panels <bold>A</bold>. and <bold>D</bold>., transversal and coronal view, respectively) and from torn SSc muscle (panels <bold>B</bold>. and <bold>E</bold>., transversal and sagittal view, respectively). A schematic illustration of muscle cross-sectional surface area (CSA) is shown in panels <bold>C</bold>. and <bold>F</bold>. (transversal and coronal view, respectively). Muscle atrophy is indicated by the dashed line of the SSc. The long head of the biceps tendon is dislocated out of the bicipital groove, medially (black arrow). Subscapularis muscle (SSc), glenoid (Gl), humeral head (HH), infraspinatus (ISp), deltoid (DM), clavicle (cla), coracoid (cor), acromion (Acr), supraspinatus (SSp) and the teres minor (Tmi). Box plot (G) shows CSA of the DM and SSC between control subjects (n = 52) and patients with a diseased SSc (n = 28). Statistical significance between DM and SSc using unpaired t-test: ** <italic>p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="oncotarget-07-8513-g001"/></fig><p>Patients with diseased SSc showed smaller cross-sectional area (CSA) of the SSc and SSp (28% and 32% lower, (<italic>p</italic> &#x0003c; 0.001 in both) respectively), whereas the RC muscles infraspinatus (ISp) and teres minor (Tmi), and the adjacent DM were not significantly different in size compared with subjects with an intact RC. In the patient group fatty infiltration was present in all four RC muscles, with highest fatty infiltration in the SSc. Among all four RC muscles, the largest contrast of atrophy and fatty infiltration between the patient group and control subjects was found in the SSc (Table <xref ref-type="table" rid="T1">1</xref>). In the DM, no fatty infiltration was found and CSA was similar in both groups (Table <xref ref-type="table" rid="T1">1</xref>). Therefore for ex-vivo analyses we compared SSc with DM.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Clinical characteristics</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Condition</th><th align="left" valign="middle" rowspan="1" colspan="1">Control subjects (<italic>n</italic> = 52)</th><th align="left" valign="middle" rowspan="1" colspan="1">Patients with diseased SSc (<italic>n</italic> = 28)</th><th align="left" valign="middle" rowspan="1" colspan="1"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age, years</td><td align="left" valign="middle" rowspan="1" colspan="1">46.0 (11.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">58.7 (9.5)</td><td align="left" valign="middle" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Female, N (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">27 (52.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">11 (39.3)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.25</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DM</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CSA, cm<sup>2</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">35.9 (7.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">38.3 (11.6)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Fatty infiltration, N (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="left" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="left" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SSc</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;CSA, cm<sup>2</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">11.9 (3.1)</td><td align="left" valign="middle" rowspan="1" colspan="1">8.6 (2.8)</td><td align="left" valign="middle" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Fatty infiltration, N (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="left" valign="middle" rowspan="1" colspan="1">22 (78.6)</td><td align="left" valign="middle" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SSp</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;CSA, cm<sup>2</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">5.0 (1.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">3.4 (1.5)</td><td align="left" valign="middle" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Fatty infiltration, N (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">8 (15.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">20 (71.4)</td><td align="left" valign="middle" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ISp</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;CSA, cm<sup>2</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">7.2 (1.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">7.0 (2.3)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.61</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Fatty infiltration, N (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">8 (15.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">19 (67.9)</td><td align="left" valign="middle" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Tmi</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;CSA, cm<sup>2</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">3.7 (1.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">3.6 (1.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.68</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Fatty infiltration, N (%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="left" valign="middle" rowspan="1" colspan="1">6 (21.4)</td><td align="left" valign="middle" rowspan="1" colspan="1"><bold>0.001</bold></td></tr></tbody></table><table-wrap-foot><p>Means (standard deviations) are provided unless otherwise stated. Deltoid (DM), cross sectional area (CSA), subscapularis (SSc), supraspinatus (SSp), infraspinatus (ISp), teres minor (Tmi). The p-values are calculated with unpaired t-tests, or chi-squared tests where appropriate.</p></table-wrap-foot></table-wrap></sec><sec id="s2_2"><title>Muscle histopathology of the SSc and DM</title><p>Muscle tissue was first investigated with H&#x00026;E staining revealing that three out of five SSc samples were highly fibrotic and nearly no myofibers were present (Figure <xref ref-type="fig" rid="F2">2</xref> and Table <xref ref-type="table" rid="T2">2</xref>). In contrast, myofibers were found in all DM sections (Figure <xref ref-type="fig" rid="F2">2</xref> and Table <xref ref-type="table" rid="T2">2</xref>). Anti-laminin immunohistochemistry confirmed the presence of myofibers in all DM samples, however only 2 out of 5 SSc samples contained myofibers (Figure <xref ref-type="fig" rid="F2">2</xref> and Table <xref ref-type="table" rid="T2">2</xref>). Nile red staining showed the presence of large fatty droplets in the SSc, which were less common in the DM (Figure <xref ref-type="fig" rid="F2">2</xref> and Table <xref ref-type="table" rid="T2">2</xref>). This staining confirmed fatty infiltration found in radiological imaging.</p><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Histological analyses in deltoid and subscapularis muscles</title><p><bold>A</bold>. Representative images of deltoid (DM) and subscapularis muscle (SSc) stained with: a. H&#x00026;E; b. Nile red (in red) for fatty droplets; c. C12-resazurin (in red) for oxidative metabolic activity. Nuclei are counterstained with DAPI in b and c ; d. Immunofluorescence with an antibody mix for MyHC-2b (green),-2a (red),-1 (blue) and laminin (white). For the SSc two conditions are shown: tissue containing myofibers (middle column) and highly fibrotic tissue without myofibers (right column). Images were taken with light microscope (a), fluorescence microscopes (b and d), or with a confocal microscope (c). Scale bars are 200 (a), 100 (b and d) or 50 (c) &#x003bc;m. <bold>B</bold>. and <bold>C</bold>. Analyses in paired samples for DM and SSc in two patients. B: Bar charts depict proportion of myofibers expressing MyHC-isotypes and those that were unstained. C: Cumulative distribution plot of the CSA in SSc, DM and vastus lateralis (VL) reference.</p></caption><graphic xlink:href="oncotarget-07-8513-g002"/></fig><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Histological observations in deltoid and subscapularis muscles</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1">Deltoid (<italic>n</italic> = 7)</th><th align="left" valign="middle" rowspan="1" colspan="1">Subscapularis (<italic>n</italic> = 5)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Myofibers in muscle</td><td align="left" valign="middle" rowspan="1" colspan="1">7/7</td><td align="left" valign="middle" rowspan="1" colspan="1">2/5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fatty droplets</td><td align="left" valign="middle" rowspan="1" colspan="1">2/7</td><td align="left" valign="middle" rowspan="1" colspan="1">5/5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fiber CSA, &#x02227;&#x003bc;m<sup>2</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">62.1 (17.5)</td><td align="left" valign="middle" rowspan="1" colspan="1">105.8 (22.6)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MyHC-2b, &#x02227;%</td><td align="left" valign="middle" rowspan="1" colspan="1">8.1 (6.9)</td><td align="left" valign="middle" rowspan="1" colspan="1">5.0 (3.7)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MyHC-2x, &#x02227;%</td><td align="left" valign="middle" rowspan="1" colspan="1">9.6 (7.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">7.0 (3.0)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MyHC-2a, &#x02227;%</td><td align="left" valign="middle" rowspan="1" colspan="1">42.9 (13.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">12.5 (10.6)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MyHC-1, &#x02227;%</td><td align="left" valign="middle" rowspan="1" colspan="1">40.1 (12.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">20.0 (7.1)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Unstained fibers, &#x02227;%</td><td align="left" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="left" valign="middle" rowspan="1" colspan="1">55.0 (6.0)</td></tr></tbody></table><table-wrap-foot><p>Analysis per sample shows the number of positive samples out of total muscle samples. Analyses carried out only from myofiber-containing sections in the subscapularis are depicted with &#x02227;. Fully degenerated muscles, as shown in Figure <xref ref-type="fig" rid="F2">2</xref>, were excluded from these analyses. Means (standard deviations) are provided unless otherwise stated. Cross sectional area (CSA), myosin heavy chain (MyHC).</p></table-wrap-foot></table-wrap><p>Defects in metabolic activity, including glycogen catabolism, fatty acid oxidation, or mitochondrial oxidative phosphorylation often affect muscle function due to high energy consumptions [<xref rid="R24" ref-type="bibr">24</xref>]. In muscle wasting conditions oxidative metabolic activity can be changed [<xref rid="R24" ref-type="bibr">24</xref>]. Oxidative metabolic activity and oxidative phosphorylation can be monitored by an irreversible conversion of C12-resazurin to fluorescent resorufin, the fluorescent resorufin can record metabolic activity in the cell [<xref rid="R25" ref-type="bibr">25</xref>]. In undamaged deltoid muscles fluorescent foci of resorufin were scattered across the fibers, indicating active myofibers (Figure <xref ref-type="fig" rid="F2">2</xref>). However, in SSc muscles the distribution of fluorescent foci across myofibers was profoundly reduced (Figure <xref ref-type="fig" rid="F2">2</xref>). This indicates that oxidative metabolic activity and oxidative phosphorylation in the SSc are reduced.</p><p>We further investigated muscle pathology using the expression of myosin heavy chain (MyHC) isotypes. We applied an immunohistochemistry procedure with a mix of antibodies to MyHC-2b, -2a and -1 isotypes to record fiber type distribution [<xref rid="R26" ref-type="bibr">26</xref>, <xref rid="R27" ref-type="bibr">27</xref>]. In both muscle tissues we found MyHC type-2a and type-1, but less frequent expression of MyHC-2b (Figure <xref ref-type="fig" rid="F2">2</xref> and Table <xref ref-type="table" rid="T2">2</xref>). In this immunostaining procedure non-stained fibers are regarded as MyHC-2x. To assess unstained myofibers, we then added an antibody to MyHC-2x. In DM samples all myofibers expressed one of the four MyHC isotypes (<xref ref-type="supplementary-material" rid="SD1">Figure S3</xref>), of which over 80% of the myofibers expressed either MyHC-2a or MyHC-1 (Table <xref ref-type="table" rid="T2">2</xref>). In the SSc muscles, however, over 50% did not stain for any MyHC isotype. Of the myofibers that expressed MyHC, the majority expressed MyHC-1 (Table <xref ref-type="table" rid="T2">2</xref>). Histological differences between diseased SSc and intact DM were further revealed in a paired analysis in the two patients with myofibers in the SSc. Above 50% of myofibers lost MyHC expression (Figure <xref ref-type="fig" rid="F2">2B</xref>) and myofiber size was dramatically increased compared with DM in the same patient (Figure <xref ref-type="fig" rid="F2">2C</xref>).</p></sec><sec id="s2_3"><title>Cellular analyses of SSc- and DM-derived myoblasts</title><p>To uncover the intrinsic molecular and cellular mechanisms underlying pathophysiological changes in chronic RC muscles, we generated muscle cell cultures from SSc muscles and Del as control. We applied this approach as the histology of chronically degenerated SSc muscle indicated that the tissue is highly fibrotic. Fatty droplets were prevalent in the SSc muscle cell cultures but were absent in the DM muscle cell cultures (Figure <xref ref-type="fig" rid="F3">3A</xref>). Within the desmin-positive cell population, myoblasts from the SSc and DM muscle cell cultures did not differ with respect to cell proliferation, apoptosis or cell senescence (Figure <xref ref-type="fig" rid="F3">3B-3E</xref>). The mitochondrial metabolic rate of the SSc myoblast cell cultures was higher than the DM myoblast cultures (Figure <xref ref-type="fig" rid="F3">3F</xref>). Moreover, we found that cell fusion in SSc derived cell culture was significantly lower compared with DM cultures (Figure <xref ref-type="fig" rid="F3">3G</xref>).</p><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Cellular activities in deltoid (DM) and subscapularis (SSc) -derived muscle cell culture (CC)</title><p><bold>A</bold>. Nile red staining in deltoid (DM) and subscapularis muscle (SSc) cell culture (CC), nuclei are counterstained with DAPI (blue). Bar chart shows the percentage of cells containing fatty droplets. <bold>B</bold>. Bar chart shows the percentage of proliferating cells. <bold>C</bold>. Box plot shows the percentage of apoptotic cells. <bold>D</bold>. Box plot shows cell senescence (normalized to the reference vastus lateralis cell culture). <bold>E</bold>. Box plot shows the mitochondrial metabolic rate (normalized to the reference vastus lateralis cell culture). <bold>F</bold>. Representative images of fused cell cultures. Myoblasts are stained with Desmin (red) and fused cells are stained with MyHC (green). Nuclei are counterstained with DAPI (blue). Box plot shows the percentage of fused cells. Averages and standard deviations are from n = 5 (DM-CC) and n = 8 (SSc-CC). Statistical significance between DM-CC and SSc-CC using unpaired t-tests: * <italic>p</italic> &#x0003c; 0.05, *** <italic>p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="oncotarget-07-8513-g003"/></fig></sec><sec id="s2_4"><title>RNA expression profiles in myoblasts</title><p>Next we assessed molecular differences between the SSc and DM derived muscle cell cultures using RNA-seq in seven patients. A paired analysis of RNA-seq data from the two muscles of the same patient revealed only few molecular differences between the SSc and DM myoblasts (Figure <xref ref-type="fig" rid="F4">4A</xref>). Ultimately, using a false discovery rate (FDR) of 0.05, only 14 genes were identified as differentially expressed between the SSAC- and DM- derived cultures (114 with nominal <italic>p</italic>-value &#x0003c; 0.01) (Figure <xref ref-type="fig" rid="F4">4A</xref>). The 114 dysregulated genes were clustered into four functional gene-ontology groups: the extracellular region (<italic>N</italic> = 18) and focal adhesion (<italic>N</italic> = 7), calcium ion binding (<italic>N</italic> = 10), inflammatory response (<italic>N</italic> = 7) and four genes clustered in skeletal muscle development (Figure <xref ref-type="fig" rid="F4">4B</xref>). The most significantly dysregulated genes (<italic>p</italic> &#x0003c; 0.05 FDR) affecting muscle cell development were down-regulated, while genes within the extracellular region, were up-regulated in the SSc myoblast cultures (Figure <xref ref-type="fig" rid="F4">4C</xref>). The expression level of muscle stem cells genes did not differ between these two myoblast cultures (<xref ref-type="supplementary-material" rid="SD1">Figure S4</xref>).</p><fig id="F4" orientation="portrait" position="float"><label>Figure 4</label><caption><title>RNA expression profiles in deltoid and subscapularis muscle-derived cell cultures</title><p><bold>A</bold>. Volcano plot shows log2 fold change (FC) versus -log10 of the p-value of all genes found in the RNA-seq (pair-wise analyses, n = 7). Red dots indicate significantly dysregulated genes (<italic>p</italic> &#x0003c; 0.05 FDR). Blue dots indicate dysregulated genes with a nominal <italic>p</italic>-value &#x0003c; 0.01. Positive or negative FC indicates higher or lower expression in subscapularis (SSc) compared with the deltoid (DM) cell cultures (CC). <bold>B</bold>. Functional gene ontology (GO) of dysregulated genes (<italic>p</italic> &#x0003c; 0.01), daughter GO clusters are connected with a line. GO clusters of muscle development are depicted in blue, in red the extracellular region, in green the inflammatory system and in yellow calcium binding. N indicates the number of genes. <bold>C</bold>. Box plot shows expression levels in SSc-CC or DM-CC for the most significantly dysregulated genes (<italic>p</italic> &#x0003c; 0.05 FDR). Fold changes between DM and SSc are depicted. Genes of the GO muscle development are marked in blue and those of the extracellular region in red. <bold>D</bold>. Representative images of fused SSc cell cultures transduced with either mock or MyoD lentivirus (LV). Myoblasts are stained with MyHC (white) and segmented in green. Nuclei are counterstained with DAPI (blue) and segmented in blue. Nuclei within segmented MyHC objects are marked in red. Scale bar is 200 &#x003bc;m. <bold>E</bold>. Plots show paired analyses of % of fused cells and total fused area between mock and MyoD LV in 4 SSc cell cultures. *: <italic>p</italic>-value &#x0003c; 0.05, using a paired T-test.</p></caption><graphic xlink:href="oncotarget-07-8513-g004"/></fig><p>To confirm that reduced expression of myogenic genes causes reduced cell fusion in SSc myoblasts cultures, we elevated MyoD expression levels using lentivirus transduction into SSc cultures, and mock virus was used as control. We assessed the myogenesis using expression of MyHC. We found that overexpression of MyoD restored myogenesis in the SSc cultures (Figure <xref ref-type="fig" rid="F4">4D</xref>). In average myogenesis was restored with an increase of 4.2% of fused cells (<italic>p</italic> &#x0003c; 0.05, paired T-test) and a 3.1 fold larger fused area (<italic>p</italic> &#x0003c; 0.05, paired T-test) (Figure <xref ref-type="fig" rid="F4">4E</xref>).</p></sec></sec><sec id="s3"><title>DISCUSSION</title><p>Chronic muscle degeneration is highly prevalent in the elderly, characterized by loss of muscle mass and muscle strength, and leads to immobility and abrogates functionality and independence. In contrast to muscle waste in acute conditions, such as muscle disuse in denervation conditions [<xref rid="R28" ref-type="bibr">28</xref>] or starvation stress [<xref rid="R29" ref-type="bibr">29</xref>], the molecular mechanisms that are affected in chronic conditions are poorly understood. We present a multidisciplinary study revealing the most affected molecular mechanisms in degenerated muscles of chronic conditions, focusing on shoulder muscles. We chose to study shoulder muscles as the mechanical stresses on muscles around this joint are comparable. Furthermore, during shoulder surgery we could obtain two muscles, diseased and healthy, from each patient and those were paired analyzed.</p><p>We show that diseased SSc muscles are loaded with fatty infiltration, fibrosis, low metabolic activity, and reduced expression of MyHC isotypes. This is in agreement with our recent study showing that torn ISp muscle show similar histological marks including fatty infiltration, fibrosis and reduced expression of MyHC isotypes [<xref rid="R17" ref-type="bibr">17</xref>]. Reduced oxidative metabolism can suggest impaired mitochondrial activity [<xref rid="R25" ref-type="bibr">25</xref>], which is often found in degenerated muscles [<xref rid="R24" ref-type="bibr">24</xref>]. Moreover, in torn ISp we found a profound increase in collagen I staining, marking thickening of the extracellular matrix. This observation agrees with up-regulation of the extracellular matrix functional group we report here in torn SSc. Extracellular thickening is among the histological marks of chronic muscle degeneration and fibrosis [<xref rid="R17" ref-type="bibr">17</xref>, <xref rid="R30" ref-type="bibr">30</xref>, <xref rid="R31" ref-type="bibr">31</xref>]. In addition, we found that genes of the muscle functional group, specifically myogenesis genes, are down-regulated in cell culture from SSc compared with DM cell culture. This observation is in agreement with reduced myogenesis in the SSc cell culture. Moreover, overexpression of MyoD in SSC culture, which was found to be down-regulated, caused an increase in cell fusion. Restoring levels of additional genes from the muscle development group, and supressing expression of ECM genes could potentially lead to enhance muscle regeneration in chronic conditions.</p><p>Despite the pronounced histological changes in diseased SSc muscle, generation of myoblast cell culture from the diseased SSc was as successful as from the DM. Myoblasts cultures from degenerated SSc differed from DM cultures by only limited cellular and molecular signatures. We found no differences in cell proliferation, senescence and apoptosis between cell cultures from diseased SSc and DM. This observation is in agreement with a recent study showing no differences in cell proliferation between SSp and DM muscles [<xref rid="R32" ref-type="bibr">32</xref>]. In the torn SSp cell fusion was unaffected [<xref rid="R32" ref-type="bibr">32</xref>]. We, however, found reduced myogenesis in the torn SSc. This difference can be explained by differences in RC pathology between these two studies. A tear limited to the SSp is considered less severe RC disease, compared to tears also involving the SSc [<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R33" ref-type="bibr">33</xref>]. We therefore suggest that in more severe RC disease, muscle pathology worsens and cells have reduced myogenic capacity.</p><p>In chronically diseased SSc or ISp muscles [<xref rid="R17" ref-type="bibr">17</xref>] reduced expression of MyHC isotypes was complemented with an increase in CSA of myofibers. Genetic loss of MyHC expression causes an increased myofiber CSA [<xref rid="R34" ref-type="bibr">34</xref>]. This suggests that in chronically degenerated muscles reduced expression of MyHC isotypes could cause loss of myofibers construction and hence muscle weakness. It remains to be investigated how torn muscle conditions lead to loss of MyHC expression. In contrast to the chronic conditions investigated here, in animal models for RC tear that were generated by acute conditions (e.g. denervation, chemically, mechanically) MyHC expression is unaffected [<xref rid="R35" ref-type="bibr">35</xref>-<xref rid="R40" ref-type="bibr">40</xref>]. This suggests that molecular mechanisms associated with acute tear conditions differ from those in chronically diseased muscles.</p><p>Our results suggest that in chronically diseased SSc, muscle regeneration could be impaired due to reduced myogenesis of the muscle stem cells in an environment of thickened extracellular matrix. Targeting the extracellular region and muscle development could open new options for therapeutic developments such as cell therapies to enhance muscle regeneration. Repression of the extracellular region could be combined with surgical repair. Transplantation of <italic>in vitro</italic> propagated myoblasts into the surgical site could support muscle regeneration towards cell based therapy development. Cell therapy could ultimately enhance muscle regeneration in a combinatorial treatment to prevent muscle re-tear. Towards this, a recent study demonstrated grafting and fusion of satellite cells from non-degenerated muscles into injured muscles in mice [<xref rid="R32" ref-type="bibr">32</xref>]. In addition, efforts to reduce the extracellular region are developed in models for Duchenne muscular dystrophy [<xref rid="R31" ref-type="bibr">31</xref>], and those could be also applied for shoulder patients to order to regenerate myofibers.</p><p>This is an explorative study, with a small patient group and data have to be interpreted with caution. However, paired analyses increase statistical power and thus led to significant results. An independent replication study to validate our results should be performed. In this study we used muscle samples from shoulder pathology at advanced stage. In this stage the SSp is mostly torn, therefore the results presented here are an underestimation of muscle degeneration affecting only the SSp, which is more prevalent but less severe compared to tears extending to the SSc [<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R33" ref-type="bibr">33</xref>]. The more severe SSc pathology gives a broad spectrum to evaluate pathophysiological changes in chronic and torn muscles.</p></sec><sec sec-type="methods" id="s4"><title>MATERIALS AND METHODS</title><p>In this explorative study redundant muscle samples were collected as waste material from eleven patients that underwent shoulder surgery at the Leiden University Medical Center between 2012 and 2013 for <italic>ex-vivo</italic> analyses. All muscles samples were collected according to the Medical Ethical regulations of the institutional ethic review board of the Leiden University Medical Center and according to the guideline &#x02018;good use of redundant tissue for clinical research&#x02019; by the Dutch Federation of Medical Research Societies. Anonymous use of redundant tissues as waste material for research purposes is according to a standard agreement with patients in our hospital.</p><sec id="s4_1"><title>Surgical procedure and muscle collection</title><p>For shoulder surgery, patients were positioned in a beach chair pose and prepared and draped in a sterile fashion for shoulder surgery under general anesthesia. All patients received standard antibiotic prophylaxis before surgery. Due to damage of the SSc muscle, waste material for sampling could easily be obtained. In all cases the diseased SSc muscle was detached from the insertion site on the greater tubercle. Additionally, DM muscle samples (about 2mm<sup>3</sup>) were collected, which resulted from splitting the DM and pectoral muscle for the surgical approach. One muscle sample of each muscle was immediately frozen in liquid nitrogen and was stored at &#x02212;80&#x000b0;C prior to the histological analyses, and the second sample was dipped into 100% Fetal Calf Serum (FCS) + 50&#x003bc;g/ml gentamycin for the establishment of myoblast cell cultures. The myoblast cell cultures were generated as described in [<xref rid="R41" ref-type="bibr">41</xref>] after 7-10 day <italic>in vitro</italic> propagation cultures reached 80-95% confluence in a 6 well plate and cells were kept frozen in liquid nitrogen.</p></sec><sec id="s4_2"><title>Histology and imaging</title><p>From seven DM and five SSc frozen samples were cryosectioned (20 &#x003bc;m) on dry ice using the Leica CM3050-S cryosection (Leica, Solms, Germany). Other samples were too small for cryosectioning. Histological analyses were: 1- hematoxylin and eosin (H&#x00026;E) staining (Standard Operating Procedure: MDC1A_M.1.2.004). 2- myofiber typing protocol is detailed in <xref ref-type="supplementary-material" rid="SD1">Supplementary Methods file</xref>. 3- Fatty droplets staining with 1 &#x003bc;M Nile red (Sigma-Aldrich, Saint Louis, Missouri, USA) followed by PBS washing. Nuclei were counterstained with DAPI. 4- Oxidative metabolic activity was assessed with 10mM C12-Resazurin (Invitrogen) incubated for 15 minutes and followed by extensive washes with 50% methanol in PBS.</p><p>All slides were stained at the same day with the same mix. Slides were mounted with Polymount (Polyscience). C12-Resazurin fluorescence was visualized with a TCS-SP5 confocal microscope. Visualization of H&#x00026;E stained sections was carried out with a Leica DFC550 light microscope. Fluorescent signals, otherwise, were captured with DM5500 microscope (Leica) using LAS AF software V2.3.6. or with Array scan VTI HCA (Thermofisher, Waltham, Massachusetts, USA). For each muscle, an unstained section was used to determine auto-fluorescence. Vastus lateralis (VL) cross-sections were used as a reference for each procedure and standardization of imaging. Per fluorophore, all muscle sections were imaged with the same configuration and exposure at the same day. Image overlay and image processing was carried out with Leica LAS AF version 2.6.0 build 7266. Image quantification was carried out with ImageJ (<ext-link ext-link-type="uri" xlink:href="http://rsbweb.nih.gov/">http://rsbweb.nih.gov</ext-link>).</p></sec><sec id="s4_3"><title>Analyses of myoblast cell cultures</title><p>For cellular and molecular analyses myoblast cell cultures were seeded simultaneously. Cellular analyses were carried out on cultures at passage 1 from eight SSc samples and five DM samples that reached 20,000 cells at the same time. Muscle cell fusion and cell senescence were carried out on cells at passage 2. Cellular analyses are schematically summarized in <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S1</xref>. RNA-seq was carried out on seven paired cultures at passage 2. The researchers were blinded to the muscle type during experimentation and analyses. The cellular analyses were performed as summarized and detailed in the <xref ref-type="supplementary-material" rid="SD1">Supplementary Methods file</xref>.</p></sec><sec id="s4_4"><title>RNA isolation and RNA analyses</title><p>Cultures from seven pairs were included in the final analysis after passing control quality (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table S1</xref>). RNA was isolated from cultures at passage 2 grown in a 12 well plate using the Nucleospin RNA II (Macherey-Nagel, D&#x000fc;ren, Germany) according to the instructions of the manufacturer, and was stored at &#x02212;80&#x000b0;C prior to analyses. RNA quality was assessed using the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, California, USA). RNAseq library preparation and pair-wise analysis to identify SSc dysregulated genes is detailed in the <xref ref-type="supplementary-material" rid="SD1">Supplementary Methods file</xref>.</p></sec><sec id="s4_5"><title>Lentiviral transduction</title><p>4 cultures of SSc at passage 2 were transduced with MyoD lentivirus [<xref rid="R42" ref-type="bibr">42</xref>] or control lentivirus (multiplicity of infection (MOI): 5. After 3 days cells were incubated at fusion conditions, 2% horse-serum in DMEM, for 5 days. Quantification of fused cells was carried out as detailed in the <xref ref-type="supplementary-material" rid="SD1">Supplementary Methods file</xref>. An average of 9158 nuclei per condition was included.</p></sec><sec id="s4_6"><title>Radiological imaging</title><p>Due to medical ethical constrains we were not allowed to associate muscle samples with medical information, therefore all MRIs of patients undergoing shoulder surgery involving SSc muscle damage (<italic>n</italic> = 28) between 2012 and 2013 were evaluated. Patients received local intra-articular analgesia and a contrast agent for arthrography <italic>via</italic> a posterior approach. Magnetic Resonance imaging with arthrography (MRA) scanning and analyses were performed as previously detailed [<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R17" ref-type="bibr">17</xref>]. As control group, 52 subjects from a previous study were included with structurally intact RC muscles [<xref rid="R9" ref-type="bibr">9</xref>]. The MRI scan of one control could not be reviewed. The institutional ethics review board waived the need for participant informed consent to review the MRIs. The MRIs were anonymized and observers were blinded for outcomes.</p></sec><sec id="s4_7"><title>Statistical analyses</title><p>All statistical analyses were performed using IBM SPSS statistics version 20 (IBM Corp, 2011, Armonk, New York, USA). Categorical data are expressed using absolute values and percentages. Parametric continuous data are described with means and 95%-confidence intervals (95%-CI). Statistical assessments were carried out with unpaired Student's t-tests, unless otherwise stated.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>SUPPLEMENTARY MATERIALS FIGURES AND TABLES</title><supplementary-material content-type="local-data" id="SD1"><media mimetype="application" mime-subtype="pdf" xlink:href="oncotarget-07-8513-s001.pdf" orientation="portrait" xlink:type="simple" id="d36e1066" position="anchor"/></supplementary-material></sec></body><back><ack><p>The authors thank dr. Stephen Tapscott for kindly providing the MyoD lentivirus. Author contributions: Biopsies were collected by JFH, AK and JN, NEV maintained the cell cultures, cellular analyses were performed by YR and VR, histological staining were performed by NKG, RNA isolation was performed by AK and VR, RNA-seq analyses were performed by ZT, WA, SMK and PACH, this study was set up by RGHH and VR, YR and JFH drafted the manuscript and all authors contributed to the discussion of the results.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>FUNDING</bold></p><p>This work is supported by the Dutch Arthritis Association (DAA), grant number RF 13-1-303.</p></fn><fn fn-type="conflict"><p><bold>CONFLICTS OF INTERESTS</bold></p><p>The authors declare no conflicts of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krause</surname><given-names>S</given-names></name></person-group><article-title>Insights into muscle degeneration from heritable inclusion body myopathies</article-title><source>Front Aging Neurosci</source><year>2015</year><volume>7</volume><fpage>13</fpage><pub-id pub-id-type="pmid">25729363</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>BT</given-names></name><name><surname>Dirks</surname><given-names>ML</given-names></name><name><surname>van Loon</surname><given-names>LJ</given-names></name></person-group><article-title>Skeletal muscle atrophy during short-term disuse: implications for age-related sarcopenia</article-title><source>Ageing ResRev</source><year>2013</year><volume>12</volume><fpage>898</fpage><lpage>906</lpage></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandri</surname><given-names>M</given-names></name><name><surname>Coletto</surname><given-names>L</given-names></name><name><surname>Grumati</surname><given-names>P</given-names></name><name><surname>Bonaldo</surname><given-names>P</given-names></name></person-group><article-title>Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies</article-title><source>JCell Sci</source><year>2013</year><volume>126</volume><fpage>5325</fpage><lpage>5333</lpage><pub-id pub-id-type="pmid">24293330</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greving</surname><given-names>K</given-names></name><name><surname>Dorrestijn</surname><given-names>O</given-names></name><name><surname>Winters</surname><given-names>JC</given-names></name><name><surname>Groenhof</surname><given-names>F</given-names></name><name><surname>van der Meer</surname><given-names>K</given-names></name><name><surname>Stevens</surname><given-names>M</given-names></name><name><surname>Diercks</surname><given-names>RL</given-names></name></person-group><article-title>Incidence, prevalence, and consultation rates of shoulder complaints in general practice</article-title><source>ScandJRheumatol</source><year>2012</year><volume>41</volume><fpage>150</fpage><lpage>155</lpage></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picavet</surname><given-names>HS</given-names></name><name><surname>Schouten</surname><given-names>JS</given-names></name></person-group><article-title>Musculoskeletal pain in the Netherlands: prevalences, consequences and risk groups, the DMC(3)-study</article-title><source>Pain</source><year>2003</year><volume>102</volume><fpage>167</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">12620608</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roquelaure</surname><given-names>Y</given-names></name><name><surname>Ha</surname><given-names>C</given-names></name><name><surname>Leclerc</surname><given-names>A</given-names></name><name><surname>Touranchet</surname><given-names>A</given-names></name><name><surname>Sauteron</surname><given-names>M</given-names></name><name><surname>Melchior</surname><given-names>M</given-names></name><name><surname>Imbernon</surname><given-names>E</given-names></name><name><surname>Goldberg</surname><given-names>M</given-names></name></person-group><article-title>Epidemiologic surveillance of upper-extremity musculoskeletal disorders in the working population</article-title><source>Arthritis Rheum</source><year>2006</year><volume>55</volume><fpage>765</fpage><lpage>778</lpage><pub-id pub-id-type="pmid">17013824</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sher</surname><given-names>JS</given-names></name><name><surname>Uribe</surname><given-names>JW</given-names></name><name><surname>Posada</surname><given-names>A</given-names></name><name><surname>Murphy</surname><given-names>BJ</given-names></name><name><surname>Zlatkin</surname><given-names>MB</given-names></name></person-group><article-title>Abnormal findings on magnetic resonance images of asymptomatic shoulders</article-title><source>JBone Joint SurgAm</source><year>1995</year><volume>77</volume><fpage>10</fpage><lpage>15</lpage></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mall</surname><given-names>NA</given-names></name><name><surname>Kim</surname><given-names>HM</given-names></name><name><surname>Keener</surname><given-names>JD</given-names></name><name><surname>Steger-May</surname><given-names>K</given-names></name><name><surname>Teefey</surname><given-names>SA</given-names></name><name><surname>Middleton</surname><given-names>WD</given-names></name><name><surname>Stobbs</surname><given-names>G</given-names></name><name><surname>Yamaguchi</surname><given-names>K</given-names></name></person-group><article-title>Symptomatic progression of asymptomatic rotator cuff tears: a prospective study of clinical and sonographic variables</article-title><source>JBone Joint SurgAm</source><year>2010</year><volume>92</volume><fpage>2623</fpage><lpage>2633</lpage></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henseler</surname><given-names>JF</given-names></name><name><surname>Raz</surname><given-names>Y</given-names></name><name><surname>Nagels</surname><given-names>J</given-names></name><name><surname>van Zwet</surname><given-names>EW</given-names></name><name><surname>Raz</surname><given-names>V</given-names></name><name><surname>Nelissen</surname><given-names>RG</given-names></name></person-group><article-title>Multivariate analyses of rotator cuff pathologies in shoulder disability</article-title><source>PLoSOne</source><year>2015</year><volume>10</volume><fpage>e0118158</fpage></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henseler</surname><given-names>JF</given-names></name><name><surname>de Witte</surname><given-names>PB</given-names></name><name><surname>de Groot</surname><given-names>JH</given-names></name><name><surname>van Zwet</surname><given-names>EW</given-names></name><name><surname>Nelissen</surname><given-names>RG</given-names></name><name><surname>Nagels</surname><given-names>J</given-names></name></person-group><article-title>Cranial translation of the humeral head on radiographs in rotator cuff tear patients: the modified active abduction view</article-title><source>MedBiolEng Comput</source><year>2014</year><volume>52</volume><fpage>233</fpage><lpage>240</lpage></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klatte-Schulz</surname><given-names>F</given-names></name><name><surname>Pauly</surname><given-names>S</given-names></name><name><surname>Scheibel</surname><given-names>M</given-names></name><name><surname>Greiner</surname><given-names>S</given-names></name><name><surname>Gerhardt</surname><given-names>C</given-names></name><name><surname>Schmidmaier</surname><given-names>G</given-names></name><name><surname>Wildemann</surname><given-names>B</given-names></name></person-group><article-title>Influence of age on the cell biological characteristics and the stimulation potential of male human tenocyte-like cells</article-title><source>EurCell Mater</source><year>2012</year><volume>24</volume><fpage>74</fpage><lpage>89</lpage></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boileau</surname><given-names>P</given-names></name><name><surname>Brassart</surname><given-names>N</given-names></name><name><surname>Watkinson</surname><given-names>DJ</given-names></name><name><surname>Carles</surname><given-names>M</given-names></name><name><surname>Hatzidakis</surname><given-names>AM</given-names></name><name><surname>Krishnan</surname><given-names>SG</given-names></name></person-group><article-title>Arthroscopic repair of full-thickness tears of the supraspinatus: does the tendon really heal?</article-title><source>JBone Joint SurgAm</source><year>2005</year><volume>87</volume><fpage>1229</fpage><lpage>1240</lpage></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauly</surname><given-names>S</given-names></name><name><surname>Stahnke</surname><given-names>K</given-names></name><name><surname>Klatte-Schulz</surname><given-names>F</given-names></name><name><surname>Wildemann</surname><given-names>B</given-names></name><name><surname>Scheibel</surname><given-names>M</given-names></name><name><surname>Greiner</surname><given-names>S</given-names></name></person-group><article-title>Do patient age and sex influence tendon cell biology and clinical/radiographic outcomes after rotator cuff repair?</article-title><source>AmJSports Med</source><year>2015</year><volume>43</volume><fpage>549</fpage><lpage>556</lpage></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castagna</surname><given-names>A</given-names></name><name><surname>Cesari</surname><given-names>E</given-names></name><name><surname>Gigante</surname><given-names>A</given-names></name><name><surname>Conti</surname><given-names>M</given-names></name><name><surname>Garofalo</surname><given-names>R</given-names></name></person-group><article-title>Metalloproteases and their inhibitors are altered in both torn and intact rotator cuff tendons</article-title><source>MusculoskeletSurg</source><year>2013</year><volume>97</volume><issue>Suppl 1</issue><fpage>39</fpage><lpage>47</lpage></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sejersen</surname><given-names>MH</given-names></name><name><surname>Frost</surname><given-names>P</given-names></name><name><surname>Hansen</surname><given-names>TB</given-names></name><name><surname>Deutch</surname><given-names>SR</given-names></name><name><surname>Svendsen</surname><given-names>SW</given-names></name></person-group><article-title>Proteomics perspectives in rotator cuff research: a systematic review of gene expression and protein composition in human tendinopathy</article-title><source>PLoSOne</source><year>2015</year><volume>10</volume><fpage>e0119974</fpage></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laron</surname><given-names>D</given-names></name><name><surname>Samagh</surname><given-names>SP</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Kim</surname><given-names>HT</given-names></name><name><surname>Feeley</surname><given-names>BT</given-names></name></person-group><article-title>Muscle degeneration in rotator cuff tears</article-title><source>JShoulderElbowSurg</source><year>2012</year><volume>21</volume><fpage>164</fpage><lpage>174</lpage></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raz</surname><given-names>Y</given-names></name><name><surname>Henseler</surname><given-names>JF</given-names></name><name><surname>Kolk</surname><given-names>A</given-names></name><name><surname>Riaz</surname><given-names>M</given-names></name><name><surname>van der Zwaal</surname><given-names>P</given-names></name><name><surname>Nagels</surname><given-names>J</given-names></name><name><surname>Nelissen</surname><given-names>RGHH</given-names></name><name><surname>Raz</surname><given-names>V</given-names></name></person-group><article-title>Patterns of age-associated degeneration differ in shoulder muscles</article-title><source>FrontAging Neurosci</source><year>2015</year><volume>7</volume><fpage>236</fpage></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gladstone</surname><given-names>JN</given-names></name><name><surname>Bishop</surname><given-names>JY</given-names></name><name><surname>Lo</surname><given-names>IK</given-names></name><name><surname>Flatow</surname><given-names>EL</given-names></name></person-group><article-title>Fatty infiltration and atrophy of the rotator cuff do not improve after rotator cuff repair and correlate with poor functional outcome</article-title><source>AmJSports Med</source><year>2007</year><volume>35</volume><fpage>719</fpage><lpage>728</lpage></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JR</given-names></name><name><surname>Cho</surname><given-names>YS</given-names></name><name><surname>Ryu</surname><given-names>KJ</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name></person-group><article-title>Clinical and radiographic outcomes after arthroscopic repair of massive rotator cuff tears using a suture bridge technique: assessment of repair integrity on magnetic resonance imaging</article-title><source>AmJSports Med</source><year>2012</year><volume>40</volume><fpage>786</fpage><lpage>793</lpage></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>PH</given-names></name><name><surname>Lien</surname><given-names>SB</given-names></name><name><surname>Shen</surname><given-names>HC</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Wu</surname><given-names>SS</given-names></name><name><surname>Lin</surname><given-names>LC</given-names></name></person-group><article-title>Long-term functional outcomes after repair of rotator cuff tears correlated with atrophy of the supraspinatus muscles on magnetic resonance images</article-title><source>JShoulderElbowSurg</source><year>2008</year><volume>17</volume><fpage>1S</fpage><lpage>7S</lpage></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>LS</given-names></name><name><surname>Wolf</surname><given-names>BR</given-names></name><name><surname>Hall</surname><given-names>MP</given-names></name><name><surname>Levy</surname><given-names>BA</given-names></name><name><surname>Marx</surname><given-names>RG</given-names></name></person-group><article-title>Indications for rotator cuff repair: a systematic review</article-title><source>ClinOrthopRelat Res</source><year>2007</year><volume>455</volume><fpage>52</fpage><lpage>63</lpage></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambers Heerspink</surname><given-names>FO</given-names></name><name><surname>van Raay</surname><given-names>JJ</given-names></name><name><surname>Koorevaar</surname><given-names>RC</given-names></name><name><surname>van Eerden</surname><given-names>PJ</given-names></name><name><surname>Westerbeek</surname><given-names>RE</given-names></name><name><surname>van &#x02018;t</surname><given-names>RE</given-names></name><name><surname>van</surname><given-names>dA-S</given-names></name><name><surname>Diercks</surname><given-names>RL</given-names></name></person-group><article-title>Comparing surgical repair with conservative treatment for degenerative rotator cuff tears: a randomized controlled trial</article-title><source>J ShoulderElbowSurg</source><year>2015</year><volume>24</volume><fpage>1274</fpage><lpage>1281</lpage></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denard</surname><given-names>PJ</given-names></name><name><surname>Burkhart</surname><given-names>SS</given-names></name></person-group><article-title>Arthroscopic recognition and repair of the torn subscapularis tendon</article-title><source>ArthroscTech</source><year>2013</year><volume>2</volume><fpage>e373</fpage><lpage>e379</lpage></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karakelides</surname><given-names>H</given-names></name><name><surname>Nair</surname><given-names>KS</given-names></name></person-group><article-title>Sarcopenia of aging and its metabolic impact</article-title><source>CurrTopDevBiol</source><year>2005</year><volume>68</volume><fpage>123</fpage><lpage>148</lpage></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talbot</surname><given-names>JD</given-names></name><name><surname>Barrett</surname><given-names>JN</given-names></name><name><surname>Barrett</surname><given-names>EF</given-names></name><name><surname>David</surname><given-names>G</given-names></name></person-group><article-title>Rapid, stimulation-induced reduction of C12-resorufin in motor nerve terminals: linkage to mitochondrial metabolism</article-title><source>JNeurochem</source><year>2008</year><volume>105</volume><fpage>807</fpage><lpage>819</lpage><pub-id pub-id-type="pmid">18205748</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregorevic</surname><given-names>P</given-names></name><name><surname>Meznarich</surname><given-names>NA</given-names></name><name><surname>Blankinship</surname><given-names>MJ</given-names></name><name><surname>Crawford</surname><given-names>RW</given-names></name><name><surname>Chamberlain</surname><given-names>JS</given-names></name></person-group><article-title>Fluorophore-labeled myosin-specific antibodies simplify muscle-fiber phenotyping</article-title><source>Muscle Nerve</source><year>2008</year><volume>37</volume><fpage>104</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">17691104</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiaffino</surname><given-names>S</given-names></name><name><surname>Reggiani</surname><given-names>C</given-names></name></person-group><article-title>Fiber types in mammalian skeletal muscles</article-title><source>Physiol Rev</source><year>2011</year><volume>91</volume><fpage>1447</fpage><lpage>1531</lpage><pub-id pub-id-type="pmid">22013216</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdijk</surname><given-names>LB</given-names></name><name><surname>Dirks</surname><given-names>ML</given-names></name><name><surname>Snijders</surname><given-names>T</given-names></name><name><surname>Prompers</surname><given-names>JJ</given-names></name><name><surname>Beelen</surname><given-names>M</given-names></name><name><surname>Jonkers</surname><given-names>RA</given-names></name><name><surname>Thijssen</surname><given-names>DH</given-names></name><name><surname>Hopman</surname><given-names>MT</given-names></name><name><surname>Van Loon</surname><given-names>LJ</given-names></name></person-group><article-title>Reduced satellite cell numbers with spinal cord injury and aging in humans</article-title><source>Medicine and science in sports and exercise</source><year>2012</year><volume>44</volume><fpage>2322</fpage><lpage>2330</lpage><pub-id pub-id-type="pmid">22776875</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiaffino</surname><given-names>S</given-names></name><name><surname>Dyar</surname><given-names>KA</given-names></name><name><surname>Ciciliot</surname><given-names>S</given-names></name><name><surname>Blaauw</surname><given-names>B</given-names></name><name><surname>Sandri</surname><given-names>M</given-names></name></person-group><article-title>Mechanisms regulating skeletal muscle growth and atrophy</article-title><source>The FEBS journal</source><year>2013</year><volume>280</volume><fpage>4294</fpage><lpage>4314</lpage><pub-id pub-id-type="pmid">23517348</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raz</surname><given-names>V</given-names></name><name><surname>Sterrenburg</surname><given-names>E</given-names></name><name><surname>Routledge</surname><given-names>S</given-names></name><name><surname>Venema</surname><given-names>A</given-names></name><name><surname>van der Sluijs</surname><given-names>BM</given-names></name><name><surname>Trollet</surname><given-names>C</given-names></name><name><surname>Dickson</surname><given-names>G</given-names></name><name><surname>van Engelen</surname><given-names>BG</given-names></name><name><surname>van der Maarel</surname><given-names>SM</given-names></name><name><surname>Antoniou</surname><given-names>MN</given-names></name></person-group><article-title>Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy</article-title><source>BMCNeurol</source><year>2013</year><volume>13</volume><fpage>70</fpage></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>CJ</given-names></name><name><surname>Perdiguero</surname><given-names>E</given-names></name><name><surname>Kharraz</surname><given-names>Y</given-names></name><name><surname>Aguilar</surname><given-names>S</given-names></name><name><surname>Pessina</surname><given-names>P</given-names></name><name><surname>Serrano</surname><given-names>AL</given-names></name><name><surname>Munoz-Canoves</surname><given-names>P</given-names></name></person-group><article-title>Aberrant repair and fibrosis development in skeletal muscle</article-title><source>SkeletMuscle</source><year>2011</year><volume>1</volume><fpage>21</fpage></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>GA</given-names></name><name><surname>Farris</surname><given-names>AL</given-names></name><name><surname>Sato</surname><given-names>E</given-names></name><name><surname>Gibbons</surname><given-names>M</given-names></name><name><surname>Lane</surname><given-names>JG</given-names></name><name><surname>Ward</surname><given-names>SR</given-names></name><name><surname>Engler</surname><given-names>AJ</given-names></name></person-group><article-title>Muscle progenitor cell regenerative capacity in the torn rotator cuff</article-title><source>JOrthopRes</source><year>2015</year><volume>33</volume><fpage>421</fpage><lpage>429</lpage></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerhardt</surname><given-names>C</given-names></name><name><surname>Lehmann</surname><given-names>L</given-names></name><name><surname>Lichtenberg</surname><given-names>S</given-names></name><name><surname>Magosch</surname><given-names>P</given-names></name><name><surname>Habermeyer</surname><given-names>P</given-names></name></person-group><article-title>Modified L'Episcopo tendon transfers for irreparable rotator cuff tears: 5-year follow-up</article-title><source>ClinOrthopRelat Res</source><year>2010</year><volume>468</volume><fpage>1572</fpage><lpage>1577</lpage></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>DL</given-names></name><name><surname>Harrison</surname><given-names>BC</given-names></name><name><surname>Sartorius</surname><given-names>C</given-names></name><name><surname>Byrnes</surname><given-names>WC</given-names></name><name><surname>Leinwand</surname><given-names>LA</given-names></name></person-group><article-title>Mutation of the IIB myosin heavy chain gene results in muscle fiber loss and compensatory hypertrophy</article-title><source>AmJPhysiol Cell Physiol</source><year>2001</year><volume>280</volume><fpage>C637</fpage><lpage>C645</lpage></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowshan</surname><given-names>K</given-names></name><name><surname>Hadley</surname><given-names>S</given-names></name><name><surname>Pham</surname><given-names>K</given-names></name><name><surname>Caiozzo</surname><given-names>V</given-names></name><name><surname>Lee</surname><given-names>TQ</given-names></name><name><surname>Gupta</surname><given-names>R</given-names></name></person-group><article-title>Development of fatty atrophy after neurologic and rotator cuff injuries in an animal model of rotator cuff pathology</article-title><source>JBone Joint SurgAm</source><year>2010</year><volume>92</volume><fpage>2270</fpage><lpage>2278</lpage></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonaldo</surname><given-names>P</given-names></name><name><surname>Sandri</surname><given-names>M</given-names></name></person-group><article-title>Cellular and molecular mechanisms of muscle atrophy</article-title><source>DisModelMech</source><year>2013</year><volume>6</volume><fpage>25</fpage><lpage>39</lpage></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruegg</surname><given-names>MA</given-names></name><name><surname>Glass</surname><given-names>DJ</given-names></name></person-group><article-title>Molecular mechanisms and treatment options for muscle wasting diseases</article-title><source>AnnuRevPharmacolToxicol</source><year>2011</year><volume>51</volume><fpage>373</fpage><lpage>395</lpage></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoigawa</surname><given-names>Y</given-names></name><name><surname>Kishimoto</surname><given-names>KN</given-names></name><name><surname>Sano</surname><given-names>H</given-names></name><name><surname>Kaneko</surname><given-names>K</given-names></name><name><surname>Itoi</surname><given-names>E</given-names></name></person-group><article-title>Molecular mechanism of fatty degeneration in rotator cuff muscle with tendon rupture</article-title><source>JOrthopRes</source><year>2011</year><volume>29</volume><fpage>861</fpage><lpage>866</lpage></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>E</given-names></name><name><surname>Regenfelder</surname><given-names>F</given-names></name><name><surname>Sussmann</surname><given-names>P</given-names></name><name><surname>Zumstein</surname><given-names>M</given-names></name><name><surname>Gerber</surname><given-names>C</given-names></name><name><surname>Born</surname><given-names>W</given-names></name><name><surname>Fuchs</surname><given-names>B</given-names></name></person-group><article-title>Adipogenic and myogenic gene expression in rotator cuff muscle of the sheep after tendon tear</article-title><source>JOrthopRes</source><year>2009</year><volume>27</volume><fpage>504</fpage><lpage>509</lpage></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gumucio</surname><given-names>JP</given-names></name><name><surname>Korn</surname><given-names>MA</given-names></name><name><surname>Saripalli</surname><given-names>AL</given-names></name><name><surname>Flood</surname><given-names>MD</given-names></name><name><surname>Phan</surname><given-names>AC</given-names></name><name><surname>Roche</surname><given-names>SM</given-names></name><name><surname>Lynch</surname><given-names>EB</given-names></name><name><surname>Claflin</surname><given-names>DR</given-names></name><name><surname>Bedi</surname><given-names>A</given-names></name><name><surname>Mendias</surname><given-names>CL</given-names></name></person-group><article-title>Aging-associated exacerbation in fatty degeneration and infiltration after rotator cuff tear</article-title><source>JShoulderElbowSurg</source><year>2014</year><volume>23</volume><fpage>99</fpage><lpage>108</lpage></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigot</surname><given-names>A</given-names></name><name><surname>Klein</surname><given-names>AF</given-names></name><name><surname>Gasnier</surname><given-names>E</given-names></name><name><surname>Jacquemin</surname><given-names>V</given-names></name><name><surname>Ravassard</surname><given-names>P</given-names></name><name><surname>Butler-Browne</surname><given-names>G</given-names></name><name><surname>Mouly</surname><given-names>V</given-names></name><name><surname>Furling</surname><given-names>D</given-names></name></person-group><article-title>Large CTG repeats trigger p16-dependent premature senescence in myotonic dystrophy type 1 muscle precursor cells</article-title><source>AmJPathol</source><year>2009</year><volume>174</volume><fpage>1435</fpage><lpage>1442</lpage></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Fong</surname><given-names>AP</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Ruzzo</surname><given-names>WL</given-names></name><name><surname>Gentleman</surname><given-names>RC</given-names></name><name><surname>Tapscott</surname><given-names>SJ</given-names></name></person-group><article-title>Comparison of endogenous and overexpressed MyoD shows enhanced binding of physiologically bound sites</article-title><source>SkeletMuscle</source><year>2013</year><volume>3</volume><fpage>8</fpage></element-citation></ref></ref-list></back></article>